Japan, Oct. 30 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'IMMUNOTHERAPEUTIC AGENTS FOR PATIENTS WHOSE TUMORS CARRY HIGH PASSENGER GENE MUTATION BURDEN.' Other related details are as follows:

Application Number: JP,2024-070240

Category (FI): A61K39/395@G,A61K39/395@T,A61K39/395@U,A61P35/00,A61P35/02,A61P43/00,121,C07K16/28,C12N15/13,C12Q1/6809@Z

Stage: Grant (IP right document published.)

Filing Date: April 24, 2024

Publication Date: July 25, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....